Thomas McHugh

Track

Insider profile

Currently holds a position at Avadel Pharmaceuticals PLC

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 25% 68% 82%
Transactions
9 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Avadel Pharmaceuticals PLC Dec. 2, 2019 -
Thomas McHugh's trades of Avadel Pharmaceuticals PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
205.70
Quantity 86,677 +42.4%
Value US$1,175,828
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-16 2024-12-13
B Purchase
68,449 +34.9%
420.58
US$1,844,685 		68,449 +34.9% 420.58 US$1,844,685
2024-12-12 2024-12-11
B Purchase
86,677 +42.4%
205.70
US$1,175,828 		86,677 +42.4% 205.70 US$1,175,828
2024-01-16 2024-01-16
B Purchase
94,907 -48.1%
347.89
US$591,157 		94,907 -48.1% 347.89 US$591,157
2023-08-14 2023-08-14
B Purchase
2,000 +2.6%
14.45
US$28,900 		2,000 +2.6% 14.45 US$28,900
2022-11-30 2022-11-29
B Purchase
5,000 +7.0%
7.80
US$39,000 		5,000 +7.0% 7.80 US$39,000
2022-05-31 2022-05-27
B Purchase
50,000 +232.6%
2.14
US$106,895 		50,000 +232.6% 2.14 US$106,895
2020-09-21 2020-09-18
B Purchase
4,000 +22.9%
6.00
US$24,000 		4,000 +22.9% 6.00 US$24,000
2020-09-01 2020-08-28
B Purchase
7,500 +75.0%
6.77
US$50,776 		7,500 +75.0% 6.77 US$50,776
2020-08-17 2020-08-13
B Purchase
10,000 +inf%
7.78
US$77,814 		10,000 +inf% 7.78 US$77,814